Clinical Trials List
Protocol NumberA6181055
2006-01-01 - 2007-12-01
Phase II
Study ended3
-
Sponsor
-
Trial scale
-
Update
2025/08/20
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- Chiun Hsu Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Study ended
Principal Investigator
Co-Principal Investigator
- Jen-Shi Chen Division of Hematology & Oncology
- Tsai-Sheng Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Study ended
Principal Investigator
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
160 participants
